JPRN-UMIN000019543招募中未知
Prospactive study for Cyclophosphamide-induced cardiomyopathy - Cyclophosphamide, prospective studdy
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2015年10月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Graft-versus-host response after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantatioWomen and men with a hematologic malignancy for which a reduced-intensity conditioning allo-SCT is indicatedMedDRA version: 19.0Level: PTClassification code 10053239Term: Prophylaxis against graft versus host diseaseSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2016-002129-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)88
进行中（未招募）
不适用
An open-label, phase II study of cyclophosphamide, lenalidomide and dexamethasone (CLD) for previously treated patients with AL amyloidosis - NDEUCTR2007-006037-13-ITOSPEDALE POLICLINICO S. MATTEO
进行中（未招募）
2 期
Short treatment with the drug cyclophosphamide in bowel cancerStage II-IVA diagnosed colorectal cancerBowel cancerCancerISRCTN12508004Cardiff University500
进行中（未招募）
不适用
_advanced solid tumor with bone metastasis and advanced pretreated osteosarcoma.EUCTR2014-000196-85-FRInstitut Bergonié
进行中（未招募）
不适用
Cyclophosphamide and Dexamethasone in combination with Ixazomib (ICD), in relpased or refractory multiple myeloma patients.Relasped and Refractory Mulitple MyelomaMedDRA version: 18.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2014-004511-36-GBniversity Of Leeds250